本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Supernus Pharmaceuticals

41.38
+0.10000.24%
成交量:78.78萬
成交額:3,250.46萬
市值:24.02億
市盈率:-21.61
高:41.84
開:41.31
低:40.75
收:41.28
52周最高:59.68
52周最低:40.51
股本:5,803.97萬
流通股本:5,166.51萬
量比:1.17
換手率:1.52%
股息:- -
股息率:- -
每股收益(TTM):-1.9145
每股收益(LYR):-0.6829
淨資產收益率:-10.49%
總資產收益率:0.39%
市淨率:2.33
市盈率(LYR):-60.60

資料載入中...

2026/08/06

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/04

企業合併公告

Form 425 - Prospectuses and communications, business combinations
2026/08/04

企業合併公告

Form 425 - Prospectuses and communications, business combinations
2026/08/03

企業合併公告

Form 425 - Prospectuses and communications, business combinations
2026/08/03

重要事件披露

Form 8-K - Current report
2026/08/03

企業合併公告

Form 425 - Prospectuses and communications, business combinations
2026/08/03

重要事件披露

Form 8-K - Current report
2026/08/03

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/03

重要事件披露

Form 8-K - Current report
2026/08/03

重要事件披露

Form 8-K - Current report
2026/08/03

企業合併公告

Form 425 - Prospectuses and communications, business combinations
2026/07/22

重要事件披露

Form 8-K - Current report
2026/06/23

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/06/18

重要事件披露

Form 8-K - Current report
2026/05/20

重要事件披露

Form 8-K - Current report
2026/05/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/06

重要事件披露

Form 8-K - Current report
2026/04/30

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/04/30

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/04/22

重要事件披露

Form 8-K - Current report